Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether zoledronic acid given once yearly for two
years to men and women after surgical repair of a recent hip fracture will significantly
reduce the rate of all re-occurring (new) osteoporotic fractures. All patients will receive
vitamin D and calcium.